Newbrik EHC Tablet (Fenofibric Acid)

Adult dose

Administer fenofibric acid 110 mg (1 tablet) orally once daily, and accompany it with dietary therapy. This medication can be taken regardless of meal timing.

This medication should not be used in patients with severe liver dysfunction or gallbladder disease. It should also not be administered to patients with severe kidney dysfunction. Pregnant or potentially pregnant women, as well as breastfeeding women, should avoid taking this medication. Patients allergic to this medication should also refrain from using it. This medication contains lactose, therefore it should not be administered to patients with lactose intolerance or certain genetic metabolic disorders. Patients with compromised kidney or liver function, hypoalbuminemia, and children should use this medication with caution. This medication can affect the liver, which may lead to elevated liver enzyme levels, cholelithiasis, and rarely, hepatitis; therefore, regular liver function tests should be conducted. Skin reactions such as itching, rash, and hair loss may occur. Neurological symptoms such as dizziness, headache, and weakness have also been reported. Myalgia or muscle cramps may occur, and in rare cases, severe issues due to muscle damage may arise; thus, if any muscle-related symptoms occur, immediate consultation with a doctor is necessary. Photosensitivity skin reactions may occur, so avoid sun exposure and be cautious if symptoms appear. Gastrointestinal symptoms such as nausea, vomiting, diarrhea, and abdominal distension may persist; if discomfort continues, notify your healthcare provider. Blood-related abnormalities such as anemia or leukopenia may arise, necessitating regular blood tests. Long-term use may worsen kidney function, necessitating ongoing kidney function assessments. During the course of taking this medication, fatigue, and in rare cases, pneumonia, cardiac arrhythmias, and weight gain may occur. Patients with impaired kidney function are at risk of severe muscle damage known as rhabdomyolysis and kidney deterioration, requiring thorough kidney function tests before and during treatment. Prior to administration, accurately check for hyperlipidemia status and consider lifestyle modifications such as dietary control, exercise, and blood pressure management. If no therapeutic effect is seen, consider discontinuing after about 3 months of treatment. Acute allergic reactions may occur; seek immediate medical attention if symptoms such as hives, difficulty breathing, or facial or neck swelling arise. This medication has numerous interactions with other drugs, so consult with your doctor and consider dose adjustments when taking it alongside cholesterol-lowering agents, anticoagulants, blood glucose-lowering agents, and gout medications. It is safest to avoid this medication during pregnancy and breastfeeding. In children, urinary difficulties may occur, necessitating caution. The elderly may have reduced liver and kidney function and may experience adverse reactions more easily, hence regular kidney function testing and careful administration are required. There are no specific antidotes for overdose, so it is vital to adhere to the prescribed dosage and notify healthcare professionals of any unusual symptoms.

Serious side effects

• Anaphylaxis
• angioedema
• acute hypersensitivity reactions
• DRESS syndrome
• severe skin reactions
• exfoliative dermatitis
• fever
• systemic organ involvement
• renal abnormalities
• hepatic abnormalities

Mild side effects

• Increased transaminases
• cholelithiasis
• hepatomegaly
• bile duct obstructive hepatitis
• itching
• skin rash
• hair loss
• dizziness
• headache
• weakness

Store this medication tightly closed in a container to protect it from air and moisture, and it is essential to keep it at room temperature between 1°C and 30°C. This storage method helps maintain the medication's effectiveness and safety.

Appearance

White, round enteric-coated tablet

Package unit

30 tablets/bottle